INTRODUCTION
containing a 1,125 bp fragment of the coding sequence on the TFII-I amino-terminal domain in an antisense direction (11) . Approximately 24 h after transfection, cells were split in a 1:3 ratio and cultured in the presence of 12 g/ml of blasticidin for at least 7 days. Stable transformants were then pooled and protein extracts were prepared from the 293T/TFII-I(N)/AS/Bsd cell lines referred to as AS cells, or from the 293T/pCIS2/Bsd cell lines referred to as V cells, and assayed for TFII-I protein levels by Western blot.
Northern Blots-The methods for total cellular RNA extraction and Northern blot hybridizations have been described previously (24) . The cDNA probes used for the detection of Grp78 and glyceraldehyde-3-phosphate dehydrogenase transcripts have also been described (16) .
Transient Transfection and Assay of Reporter Gene Activity-For the CAT assay,
NIH3T3 cells were seeded in 6-well plates and grown to about 60-80% confluence. One g of the -457CAT, (-109/-74)MCAT or MCAT reporter plasmid was co-transfected with 1 g of pCH110, an expression vector for -galactosidase under the control of the SV40 promoter, which was used as an internal control for transfection efficiency. For stress induction, 24 h after transfection the cells were treated with Tg, genistein, or Tg combined with genistein for 16 h prior to harvesting. Preparation of the cell lysates for CAT assays and the quantitation of the CAT assays have been described (20) . Cell extracts corresponding to equal -galactosidase units were used.
For the luciferase assay, NIH3T3 cells or 293T cells were grown to 60-80% confluence. One g of the -169/Luc reporter gene was co-transfected with various amounts of pEBGTFII-I, pEBGTFII-I(YY-FF), Src, or Src(DN) plasmids alone or in combination using PolyFect (Qiagen, Valencia, CA). The amount of total DNA in each transfection was adjusted to be the same by addition of the empty vector in the reaction mixture. The transfected cells were either grown in non-stress conditions or subjected to Tg or Tuni treatment. After drug treatment, cell lysates were prepared for luciferase assays using the Luciferase Assay System (Promega, Madison, WI). Each transfection was performed in duplicate and repeated three or four times.
Western Blotting-Conditions for Western blot analysis of GRP78 and GRP94 with the anti-KDEL mouse monoclonal antibody (StressGen, Victoria, BC, Canada) have been described previously (3) . Conditions for Western blot analysis of endogenous TFII-I and -actin have been described previously (11) . For detection of phosphorylated GST-TFII-I, an anti-pY rabbit polyclonal antibody (a gift from Dr. Wei Li, University of Southern California) was used as the primary antibody at a dilution of 1:500. The secondary antibody used was horseradish peroxidase-conjugated goat anti-rabbit (Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:2,000. For detection of phosphorylated c-Src, the anti-Src-pY418 rabbit polyclonal antibody (Affinity BioReagents Inc, Golden, CO) was used as the primary antibody at a dilution of 1:1,000.
The secondary antibody used was horseradish peroxidase-conjugated goat anti-rabbit (Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:2,000. For detection of c-Src, the anti-Src mouse monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used as the primary antibody at a dilution of 1:1,500. The secondary antibody used was horseradish peroxidase-conjugated goat anti-mouse (Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:3,000. Visualization of the protein bands was performed by the ECL Chemiluminescence kit (Amersham).
Immunoprecipitation-293T cells were transfected with either wild-type GST-tagged TFII-I or GST-tagged TFII-I(YY-FF). Whole cells were lysed in cell lysis buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mG EGTA, 1%Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM DTT, 1 mM Na 3 VO 4 ) with the addition of one protease inhibitor cocktail tablet (Roche) per 10 ml lysis buffer before use. Cell lysates were cleared by centrifugation at 12,000 xg for 10 min at 4°C. For immunoprecipitation, 300 g of whole cell lysates were incubated with protein A-Sepharose beads (Sigma) and 6 l of rabbit anti-GST polyclonal antibody (Sigma). After the incubation, the beads were washed four times with cold lysis buffer. The immunoprecipitates were divided into two sets. One set was subjected to immunoblotting with anti-pY antibody and another set was subjected to immunoblotting with anti-GST antibody.
Chromatin Immunoprecipitation Assays-NIH3T3 cells were grown in 15 cm plates under normal cell culture conditions to 80% confluence and treated with 300 nM Tg for 3 h. Conditions for Chromatin Immunoprecipitation Assay have been described previously (23) . Equal amounts of chromatin from each sample were incubated at 4°C overnight with 5 l of anti-TFII-I antibody (BD Biosciences) or 5 l of anti-H3 antibody (Santa Cruz Biotechnology Inc.). The primers used for the endogenous Grp78 promoter were 5'-CATTGGTGGCCGTTAAGAATGACCAG (forward) and 5'-AGTATCGAGCGCGCCG TCGC (reverse), yielding a 223-bp product.
Immunofluorescence Staining-Swiss 3T3 cells were seeded on coverslips. Twentyfour h later, cells were serum starved in DMEM containing 0.4% calf serum for 36 h. 
RESULTS

Induction of TFII-I Upon ER Stress Precedes
Grp Induction-To follow the kinetics of ER stress-mediated TFII-I induction at the protein level, we utilized the NIH3T3 cell line where the basal TFII-I level is lower compared to other cell lines. Upon Tg stress, there was a substantial increase in the TFII-I protein level (Fig. 1A) . Consistent with TFII-I being a transcription activator for Grp78, the kinetics of increase in TFII-I protein level following Tg treatment preceded the increase in GRP78 and GRP94 levels (Fig. 1A ).
This was also observed when the cells were treated with Tunicamycin (Tuni) (Fig. 1B) .
To examine whether TFII-I associates with the Grp78 promoter in vivo, chromatin immunoprecipitation (ChIP) assays were performed with NIH3T3 cells subjected to Tg treatment. Using the anti-TFII-I antibody as the immunoprecipitating antibody and equal amounts of input DNA, we detected minimal TFII-I binding to the Grp78 promoter in nonstressed cells; upon 30 min of Tg treatment, there was a significant increase in TFII-I binding (Fig. 1C, middle panel) . In contrast, core histone H3 binding to the same promoter region was similar before and after Tg treatment (Fig. 1C, lower panel) . These results suggest that in this cell line an increase in TFII-I level can result in Grp78 induction. This was confirmed when NIH3T3 cells were co-transfected with -169/Luc and an expression vector for TFII-I and an increase in luciferase activity was observed in a dose-dependent manner with ectopic TFII-I (Fig. 1D) .
TFII-I is a Target of ER-stress Induced Tyrosine Phosphorylation that is Inhibited by
Genistein-A schematic drawing of the unique structural domains of TFII-I with the location of the tyrosine residues Y248 and Y249 being highlighted is shown in Fig. 2A .
To confirm that the tyrosine phosphorylation site at Y248 and Y249 are critical for its transactivating activity on the Grp78 promoter, 293T cells were co-transfected with -169/Luc and GST-tagged wild-type TFII-I or TFII-I(YY-FF) in which the two tyrosine residues are mutated to phenylalanine. The wide-type TFII-I was able to stimulate the -169/Luc reporter while TFII-I(YY-FF) had no effect (Fig. 2B ). This is consistent with the previous observation that while the site at Y248 and Y249 are not required for the TFII-I to bind to DNA, they are critical for its transactivating activity (15) .
To test whether ER stress affects the status of TFII-I tyrosine phosphorylation and whether this process is dependent on the site at Y248 and Y249, 293T cells were transfected with GST-tagged wild-type TFII-I or TFII-I(YY-FF). The cells were either untreated, or treated with Tg or genistein, or in combination of the two ( suggest that Tg-stress induced tyrosine phosphorylation of TFII-I occurs primarily on the tyrosine site at Y248 and Y249 and that this event can be suppressed by genistein.
Genistein Inhibits ER-stress Induction of the Grp78
Promoter through the ERSE-Extending our previous observation that genistein has no effect on the basal expression level of Grp78 but can suppress Grp78 induction by AzC (16), we observed that genistein can also inhibit the activation of Grp78 by Tg and Tuni (data not shown).
Thus, genistein is a general inhibitor of ER stress inducers. To test if the mechanism of such inhibition by genistein is mediated through the ERSE of the Grp78 promoter, CAT reporter gene assay was selected instead of firefly luciferase reporter gene assay since we discovered that genistein, an ATPase inhibitor, inhibits the enzymatic activity of luciferase (data not shown). Three reporter genes were tested in these assays (Fig. 4A ).
They are -457CAT which contains 457 bp of the native Grp78 promoter driving the CAT reporter gene, (-109/-74)CAT which contains two copies of the ERSE1 cloned upstream of the minimal MMTV promoter containing essentially the TATA element, and the empty cloning vector pMCAT. The transfected cells were either un-treated, or treated with Tg or genistein, or in combination. We observed that genistein did not affect the basal promoter activity of any of the constructs but was able to suppress Tg induction in constructs that contained the ERSE linked to either its native promoter, as in the case of -457CAT, or a heterologous promoter, as in the case of (-109/-74)MCAT. These results are consistent with a genistein target being a transcription factor such as TFII-I that binds and acts through the ERSE of the Grp78 promoter.
ER-stress Induces Tyrosine Phosphorylation of TFII-1 and Nuclear Localization-
Since Y248 of TFII-I has been shown to be critical for Grp78 activation, we sought to determine whether Tg stress induces phosphorylation specifically at this site.
Immunofluorescence staining for phosphorylated TFII-I was performed with Swiss 3T3 cells either un-treated or treated with Tg. A specific antibody against TFII-I phosphorylated at Y248 was used (Fig. 4) (17) . We observed that in non-stressed cells, the pY248-TFII-I antibody staining was negligible and predominantly in the cytoplasm.
Upon Tg treatment, antibody staining was dramatically enhanced and found exclusively in the nucleus.
Tg-stress Induces Tyrosine Phosphorylation of c-Src and TFII-I Transcriptional
Stimulation of the Grp78 Promoter-TFII-I is phosphorylated at Y248 in a c-Src (Fig. 5A) . Hence, the kinetics of Src phosphorylation/activation correlates with the Tg stress induced phosphorylation of TFII-I at Y248 (Fig. 4) .
To examine whether overexpression of c-Src can result in Grp78 induction, increasing amounts of the wild-type c-Src expression plasmid were co-transfected with -169/Luc reporter gene. We observed that c-Src could enhance the Grp78 promoter activity in a dose-dependent manner in the absence of ER stress (Fig. 5B , lanes 2 to 5). At the highest dose, a 3-fold induction was achieved as compared to the 4-fold induction by Tg treatment. Consistent with c-Src contributing to Tg induction of the Grp78 promoter, expression of dominant negative c-Src attenuated Tg-stress of its target genes in vivo. We observed that the basal level of Grp78 transcripts in the AS cell line is 40% lower than that of V cell line and that the induction of Grp78 transcripts by Tg and Tuni was reduced by about 60% in the AS cell line, as compared to the V cell line (Fig. 6B) . This provides direct evidence that TFII-I is required in vivo for optimal induction of endogenous Grp78 transcripts by ER stress.
To follow the kinetics of induction of GRP78 at the protein level in the AS and V cell lines, total cell lysates were prepared from cells treated with Tg for 2, 8 and 16 h.
Western blot was performed to detect the level of GRP78 as well as GRP94, an ER calcium-binding molecular chaperone which is commonly coordinately regulated with GRP78 (7, 25) . In addition, the same extract was probed for the level of TFII-I andactin. As shown in Fig. 7 , the induction of both GRP78 and GRP94 protein by Tg was suppressed in the AS cell line, which had a reduced TFII-I level.
DISCUSSION
The transcriptional upregulation of ER chaperones by ER stress as exemplified by GRP78 induction is an important pathway since ER stress can induce the UPR which can bring on cell death as well as pro-survival mechanisms. The interplay between these processes has clinical implications in neurodegenerative diseases, atherosclerosis, diabetes and cancer (5, (26) (27) (28) . Most studies on the transcription activation of Grp78 have focused on the transcription factors such as ATF6, NF-Y and YY1 that interact with the ERSE (10,13,23,29-31). While recent evidence suggests that additional control elements outside the ERSE can also modulate Grp78 promoter activity in response to ER stress, site-directed mutagenesis of the Grp78 promoter clearly indicates that the ERSE is still the primary regulatory element for the ER stressmediated transcription activation of the Grp78 promoter (9,32).
Through biochemical fractionation and subsequent microsequencing, we have previously identified TFII-I as a novel activator of the ERSE through binding to the GCrich sequence motif of the ERSE (11) . Interestingly, the level of TFII-I transcript and protein increases in response to a variety of ER stresses, thus TFII-I provides the first example of a transcription factor that regulates UPR target genes and is itself inducible by the UPR at the transcript level. Here we further investigate into the mechanism of Tg stress-induced TFII-I activation of the Grp78 promoter. These studies reveal several novel observations, including Tg stress induced activation of c-Src and enhanced tyrosine phosphorylation of TFII-I at Y248, as well as Tg stress-induced nuclear localization of this phosphorylated form of TFII-I and enhanced binding of TFII-I to the Grp78 promoter in vivo resulting in promoter activation (Fig. 8) . Our observations are consistent with emerging evidence that under quiescent conditions and using an antibody that can distinguish between different TFII-I isoforms, TFII-I is mostly cytoplasmic and translocates into the nucleus upon tyrosine phosphorylation (17,33).
We further tested the functional significance of TFII-I in GRP induction by establishing stable cell lines that express antisense RNA targeted against TFII-I. In these cells, the steady state level of TFII-I was reduced substantially and the TFII-I level remained low after ER stress. Using these cells and control cells similarly transfected with the empty vector, we demonstrate that TFII-I is required for optimal induction of GRP78, and by extension, other members of the GRP family. This is supported by the observation that GRP94, a major ER glycoprotein chaperone that is co-regulated with GRP78 at the transcription level, is also dependent on TFII-I for full induction following ER stress (25) .
Further, the requirement of TFII-I is not restricted to ER calcium depletion stress, since other stress conditions, such as blockage of protein N-linked glycosylation, as well as production of malfolded proteins, also require TFII-I to optimally induce the GRPs.
The observation that TFII-I is a rate-limiting transcription factor for Grp induction raises the critical question as to why it is essential for optimal Grp promoter activation.
Previously we discovered that TFII-I is a co-activator for ATF6 (11) . Although ATF6 is able to bind the ERSE, it requires the presence of other factors in the nuclear extract (30). Thus, one possible mechanism is that TFII-I, through its unique structure of multiprotein interactive domains, can stabilize ATF6 binding to the ERSE, in cooperation with other binding factors such as NF-Y and YY1. Consistent with this notion is the observation that optimal ATF6 activation of the ERSE is dependent on TFII-I (11). In addition, TFII-I may also facilitate the communication of upstream activating complexes to the basal transcription machinery (14). Thus, the dual role of TFII-I in enhancing multi-factor complex formation and cross-talk to the basal promoter core elements could explain in part why reducing the amount of TFII-I in cells will substantially suppress ERstress induction of Grp78 transcription.
Another critical role for TFII-I may involve integrating a novel ER stress-induced tyrosine kinase signaling pathway to the induction of ER chaperone gene promoters.
The existence of a tyrosine kinase pathway in regulating the ER stress response was first discovered through the observation that genistein, a tyrosine kinase inhibitor, can largely eliminate the increase of Grp78 transcription by Tg and that this suppression is mediated through the ERSE (24) . The inhibitive effect of genistein is general since it also suppresses induction by AzC as well as tunicamycin. It was further determined that treatment of cells with genistein results in the disruption of transcription factor binding to the ERSE (16) . However, how genistein suppresses the ER stress response is not understood. Here we propose that TFII-I could be one target for the inhibitive effect of genistein based on the following novel observations uncovered in this study (Fig 8) .
First, TFII-I undergoes dramatic increase in tyrosine phosphorylation after ER stress.
The phosphorylation involves the site at tyrosine residues at Y248 and Y249, since the ER stress-mediated increase in phosphorylation is largely eliminated when these residues are mutated. Further, through the use of specific antibody against phosphorylated Y248, we showed a dramatic increase in TFII-I phosphorylation at this site and subsequent nuclear localization upon ER stress. Previously it has been established that these residues are required for the transcription function of TFII-I (15).
Here, we re-affirmed that specific mutation of these two residues results in complete loss of the transcriptional activity of TFII-I on the Grp78 promoter. Finally, we showed that genistein could block the ER stress induced tyrosine phosphorylation of TFII-I.
Previous work shows that the tyrosine phosphorylation at the Y248 and Y249 site is not required for the DNA binding property of TFII-I (15). Thus, one possible mechanism is that the phosphorylation status of TFII-I at these critical residues affects its ability to complex with other proteins, thereby interfering with its ability to stabilize the Grp complex and disrupting its activating function.
In support of our previous study identifying c-Src as a potential kinase mediating tyrosine phosphorylation of TFII-I on Y248 (17), we discover that c-Src is activated by 
